-
News | 2022.10.19
Interview: INRAE and the Institut Pasteur strengthen their collaboration
The Institut Pasteur and INRAE are strengthening their partnership to tackle infectious and toxic risks and prevent zoonotic diseases. Christophe d'Enfert, Senior Executive Scientific Vice-President at the Institut Pasteur, tells us about the importance of this partnership that focuses on the biology of living systems with the aim of improving animal and human health.
-
Page avancée | 2022.10.25
Our Sars-Cov-2 research projects
Our Sars-Cov-2 research projects
-
Document de presse | 2022.10.19
The Black Death shaped the evolution of immunity genes, setting the course for how we respond to autoimmune diseases today, researchers find
Researchers from the Institut Pasteur, McMaster University and the University of Chicago have identified genes that protected some individuals against the devastating bubonic plague pandemic that swept through Europe, Asia and Africa nearly 700 years ago. The same genes that once conferred protection against the Black Death are today associated with an increased susceptibility to autoimmune...
-
Document de presse | 2022.10.21
SpikImm announces the clinical trials start for SPK001, its monoclonal antibody against SARS-CoV-2
SPK001, the first anti-SARS Cov2 monoclonal antibody candidate of SpikImm, a French biotechnology company founded by Truffle Capital, originally discovered by the Institut Pasteur's Human Immunology Laboratory, directed by Dr. Hugo Mouquet (Inserm Joint Research Unit), has been tested on three initial cohorts of healthy volunteers, and has demonstrated excellent tolerance, in the context of the...
-
Document de presse | 2022.10.30
Institut Pasteur Welcomes New, Comprehensive Relationship With UCSF QBI
Two Academic and Scientific Heavyweights Agree to Implement Joint Actions Towards the Creation of a Center of Excellence in Emerging Infectious Diseases with Planned Operations/Locations in Paris and San Francisco. In a ceremony on October 21, 2022, the Institut Pasteur and UC San Francisco Quantitative Biosciences Institute (UCSF QBI) announced a new partnership for the joint establishment...
-
Article | 2022.11.10
Diversity, Equity, and Inclusion (DEI) Commitment
We are proud to state that diversity is our greatest asset in our fight for human health. “Science knows no country, because knowledge belongs to humanity”, as Louis Pasteur said.
-
News | 2022.10.21
New progress on the genetic factors involved in dyslexia
Three studies conducted by an international consortium, published in the journals Molecular Psychiatry, PNAS and Nature Genetics, have revealed several dozens of genes associated with dyslexia and reading skills. These analyses, performed on a large number of participants, have enabled scientists to detect the first genetic variations associated with dyslexia and reading skills in genes involved...
-
News | 2022.10.27
Hospital-acquired infections: a key molecule that helps Clostridium difficile adapt to the gut environment
Hospital-acquired infections caused by Clostridioides difficile represent a major health threat. In a recently published study, scientists describe the molecular mechanisms that enable the bacteria to survive, adapt and develop in the gut. They demonstrate that the c-di-AMP molecule plays a central role in C. difficile's internal regulation mechanisms, promoting antimicrobial resistance.
-
Événement | 2022.12.02
Epidemic, pandemic... Infodemic: the other health emergency
The symposium called "Epidemic, pandemic... Infodemic: the other health emergency", organized by Université Paris Cité and the Institut Pasteur, will be held on December 2, 2022. This event will take place at the Institut Pasteur (Paris, 15th arrondissement), in French. Registration is free but mandatory.(This event will be held in French)Les questions de communication et d’information...
-
News | 2022.11.14
Monkeypox: a detailed profile of the disease
Physicians and scientists from the Institut Pasteur, the Pasteur Network and ANRS | Emerging Infectious Diseases have conducted a review of the medical and scientific literature about monkeypox. The review, which paints a complete picture of the disease, was published in the New England Journal of Medicine on October 26, 2022. What are the signs of this disease? Where does it come from? How is it...
